ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu

Reference Electrodiagnostic Data Study (Normative Data)

About the Study

Principal Investigator: Michael Benatar, MD, PhD

300px-Linear_regression.svgThe interpretation of nerve conduction study data requires an appreciation of the range of values that might be encountered in a normal healthy population. In this study, commonly used nerve conduction studies were performed in a large group of healthy volunteers. The data were analyzed using a technique known as quantile regression to develop reference data (sometimes called normative data) for the nerve conduction studies commonly used in routine clinical practice.

Eligibility Criteria
  • No sensory (numbness, tingling, neuropathic pain) or motor (weakness) symptoms in the arms or legs
  • No history of alcohol consumption (> 2 alcoholic beverages per day over a period of > 4 weeks)
  • No history of exposure to neurotoxic drugs
  • No history of diabetes, impaired glucose tolerance, untreated thyroid, kidney or liver disease
  • No family history of neuropathy
  • Normal neurological examination
Funding Agencies

Emory Univ

Emory University Research Committee

Collaborators
  • Joanne Wuu, ScM
  • Ruosha Li
  • Limin Peng, PhD
Contact

Principal Investigator

  • Michael Benatar, MD, PhD

Contact Information

  • Email: mbenatar@med.miami.edu
Links
  • Developing reference data for nerve conduction studies: an application of quantile regression
  • Reference data for commonly used sensory and motor nerve conduction studies
Publications
  • Peng L, Wuu J, Benatar M. Developing reference data for nerve conduction studies: an application of quantile regression. Muscle & Nerve 2009 40(5); 763-771. [ PubMed Link ]
  • Benatar M, Wuu J, Peng L. Reference data for commonly used sensory and motor nerve conduction studies. Muscle & Nerve 2009 40(5): 772-794. [ PubMed Link ]
Presentations and Lectures

Back to Research Studies

Active Research Studies

  • Research Studies (All)
  • Pre-fALS
  • CReATe PGB
  • PRESS-ALS
  • CRiALS Biomarker
  • CRiALS Genetics
  • Neuraltus NP001

Contact Us

By phone:
For familial ALS and general inquiries:
1-888-413-9315
For the CReATe Consortium and related studies:
1-844-837-1031

By email:
fals@miami.edu (For familial ALS inquiries)
projectcreate@miami.edu (For CReATe inquiries)
alsresearch@miami.edu (General inquiries)

Support Our Research

Affiliates

  • CReATe Consortium
  • CReATe Connect
  • The Kessenich Family ALS Center at UM
  • ALS Recovery Fund
  • ALS Association
  • Muscular Dystrophy Association
  • CDC National ALS Registry
  • The Northeastern ALS Consortium
  • Myasthenia Gravis Research Group
Read Our Newsletter

News

  • Biomarker for ALS Disease Progression Identified by the Teams at University of Miami and Flinders University!03/07/2017 - 5:48 pm
  • Brain MedicineDr. Benatar presents promising phase II trial results of Arimoclomol in SOD1 ALS12/09/2016 - 5:02 pm
  • CReATe Consortium Virtual Journal Club12/08/2016 - 3:18 pm
More News
© Copyright - ALS Research Collaboration. Site by Academic Web Pages
Scroll to top
Translate »